WebMay 11, 2024 · Telara Pharma - Funding, Financials, Valuation & Investors Organization Telara Pharma Summary Financials People Technology Signals & News Similar Companies Highlights Funding Rounds 1 Total Funding Amount €100K Lead Investors 1 Investors 1 Funding Telara Pharma has raised a total of €100K in funding over 1 round. WebArch Biopartners is a clinical stage company developing new drug candidates for treating organ damage caused by inflammation; Novel Mechanism of Action – selective dipeptidase-1 (DPEP-1 ...
GENESIS Biomed has led the closing of a € 100,000 seed round for Telara ...
WebCompany type: Sociedad Limitada, Active: VAT Number (CIF) B02839470: Universal Entity Code: 8351-6250-1732-0076: Record last updated: Thursday, July 21, 2024 8:56:16 PM UTC WebApr 16, 2024 · Arch Biopartners Inc. has announced the signing of a licensing agreement with Telara Pharma SL for its patents relating to Cilastatin, dipeptidase-1 (DPEP-1) antagonists. The licensing deal which awards commercial rights for the patents, is put through mainly for Arch to use them in developing a treatment for acute kidney injury. simplify 1 - 3
Scrip
Web--Arch Biopartners Inc., announced today it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain to clinically develop and market cilastatin, a small-molecule drug ... WebTelara Pharma has designed a drug capable of preventing acute kidney injury. Headquarters Location Madrid, Spain Suggest an edit Missing: Telara Pharma 's … WebTelara Pharma – Developing therapeutic solutions for the prevention and treatment of kidney disease and sepsis. We use cookies on our website to give you the most relevant … Acute kidney Injury (AKI) is a syndrome that results in a sudden decrease in kidney … Cilastatin: a potential treatment strategy against COVID-19 that may decrease … Telara Pharma awarded at the 8th IiSGM Research and Innovation Conference … Telara Pharma S.L. is a spin-off company from the Gregorio Marañón Health … Great! Thank you for you message! We will get back to you real soon. With the creation of Telara Pharma to try to bring cilastatin into clinical use, we … Company (referred to as either “the Company”, “We”, “Us” or “Our” in this … Telara Pharma S.L. has been created in Madrid (Spain), acquiring a license … simplify 132 : 48